Welcome!

News Feed Item

Acute Heart Failure Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Acute Heart Failure Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

Acute Heart Failure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 6
Acute Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Heart Failure 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29

Prominent Sponsors 30
Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Acute Heart Failure 33
Jul 28, 2014: Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Nile Therapeutics, Inc. 35
Clinical Trial Overview of Nile Therapeutics, Inc. 35
Cardiorentis AG 36
Clinical Trial Overview of Cardiorentis AG 36
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Abbott Laboratories 38
Clinical Trial Overview of Abbott Laboratories 38
Cytokinetics, Inc. 39
Clinical Trial Overview of Cytokinetics, Inc. 39
Biogen Idec Inc. 40
Clinical Trial Overview of Biogen Idec Inc. 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Alere Inc. 42
Clinical Trial Overview of Alere Inc. 42

Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
Clinical Trial Overview of Top Institutes / Government 44
Duke University 44
Clinical Trial Overview of Duke University 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
University Hospital Basel 46
Clinical Trial Overview of University Hospital Basel 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
French Cardiology Society 48
Clinical Trial Overview of French Cardiology Society 48
Northwestern University 49
Clinical Trial Overview of Northwestern University 49
University Hospital of Larissa 50
Clinical Trial Overview of University Hospital of Larissa 50
The Cleveland Clinic 51
Clinical Trial Overview of The Cleveland Clinic 51
Hebei Medical University 52
Clinical Trial Overview of Hebei Medical University 52
YAMAGUCHI UNIVERSITY 53
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Acute Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Nile Therapeutics, Inc., 2014* 35
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiorentis AG, 2014* 36

Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 38
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014* 39
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 40
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 41
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alere Inc., 2014* 42
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 43
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 44
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2014* 45
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 46
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 47
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2014* 48
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 49
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2014* 50
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 51
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hebei Medical University, 2014* 52
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by YAMAGUCHI UNIVERSITY, 2014* 53

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 82

To order this report: Acute Heart Failure Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
The cloud competition for database hosts is fierce. How do you evaluate a cloud provider for your database platform? In his session at 18th Cloud Expo, Chris Presley, a Solutions Architect at Pythian, gave users a checklist of considerations when choosing a provider. Chris Presley is a Solutions Architect at Pythian. He loves order – making him a premier Microsoft SQL Server expert. Not only has he programmed and administered SQL Server, but he has also shared his expertise and passion with budd...
Apache Hadoop is emerging as a distributed platform for handling large and fast incoming streams of data. Predictive maintenance, supply chain optimization, and Internet-of-Things analysis are examples where Hadoop provides the scalable storage, processing, and analytics platform to gain meaningful insights from granular data that is typically only valuable from a large-scale, aggregate view. One architecture useful for capturing and analyzing streaming data is the Lambda Architecture, represent...
SYS-CON Events announced today that Ocean9will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Ocean9 provides cloud services for Backup, Disaster Recovery (DRaaS) and instant Innovation, and redefines enterprise infrastructure with its cloud native subscription offerings for mission critical SAP workloads.
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
In his session at DevOps Summit, Tapabrata Pal, Director of Enterprise Architecture at Capital One, will tell a story about how Capital One has embraced Agile and DevOps Security practices across the Enterprise – driven by Enterprise Architecture; bringing in Development, Operations and Information Security organizations together. Capital Ones DevOpsSec practice is based upon three "pillars" – Shift-Left, Automate Everything, Dashboard Everything. Within about three years, from 100% waterfall, C...
Adding public cloud resources to an existing application can be a daunting process. The tools that you currently use to manage the software and hardware outside the cloud aren’t always the best tools to efficiently grow into the cloud. All of the major configuration management tools have cloud orchestration plugins that can be leveraged, but there are also cloud-native tools that can dramatically improve the efficiency of managing your application lifecycle.
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Some people worry that OpenStack is more flash then substance; however, for many customers this could not be farther from the truth. No other technology equalizes the playing field between vendors while giving your internal teams better access than ever to infrastructure when they need it. In his session at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will talk through some real-world OpenStack deployments and look into the ways this can benefit customers of all sizes....
Deep learning has been very successful in social sciences and specially areas where there is a lot of data. Trading is another field that can be viewed as social science with a lot of data. With the advent of Deep Learning and Big Data technologies for efficient computation, we are finally able to use the same methods in investment management as we would in face recognition or in making chat-bots. In his session at 20th Cloud Expo, Gaurav Chakravorty, co-founder and Head of Strategy Development ...
SYS-CON Events announced today that Linux Academy, the foremost online Linux and cloud training platform and community, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Linux Academy was founded on the belief that providing high-quality, in-depth training should be available at an affordable price. Industry leaders in quality training, provided services, and student certification passes, its goal is to c...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Interoute has announced the integration of its Global Cloud Infrastructure platform with Rancher Labs’ container management platform, Rancher. This approach enables enterprises to accelerate their digital transformation and infrastructure investments. Matthew Finnie, Interoute CTO commented “Enterprises developing and building apps in the cloud and those on a path to Digital Transformation need Digital ICT Infrastructure that allows them to build, test and deploy faster than ever before. The int...